Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Pfizer (PFE) has a market cap of $148.34 billion USD. According to our data, Pfizer is ranked No.105 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $148.34 B |
-1.33%
|
| Dec 31, 2024 | $150.35 B |
-2.22%
|
| Dec 29, 2023 | $153.75 B |
-41.26%
|
| Dec 30, 2022 | $261.77 B |
-10.41%
|
| Dec 31, 2021 | $292.18 B |
66.70%
|
| Dec 31, 2020 | $175.28 B |
3.07%
|
| Dec 31, 2019 | $170.06 B |
-6.91%
|
| Dec 31, 2018 | $182.68 B |
24.82%
|
| Dec 29, 2017 | $146.36 B |
15.90%
|
| Dec 30, 2016 | $126.28 B |
4.42%
|
| Dec 31, 2015 | $120.92 B |
7.09%
|
| Dec 31, 2014 | $112.92 B |
5.28%
|
| Dec 31, 2013 | $107.26 B |
26.21%
|
| Dec 31, 2012 | $84.99 B |
20.43%
|
| Dec 30, 2011 | $70.57 B |
28.78%
|
| Dec 31, 2010 | $54.80 B |
0.32%
|
| Dec 31, 2009 | $54.63 B |
8.20%
|
| Dec 31, 2008 | $50.49 B |
-16.96%
|
| Dec 31, 2007 | $60.80 B |
-8.14%
|
| Dec 29, 2006 | $66.18 B |
15.26%
|
| Dec 30, 2005 | $57.42 B |
-10.63%
|
| Dec 31, 2004 | $64.25 B |
-22.30%
|
| Dec 31, 2003 | $82.69 B |
17.75%
|
| Dec 31, 2002 | $70.23 B |
-22.16%
|
| Dec 31, 2001 | $90.22 B |
-12.47%
|
| Dec 29, 2000 | $103.07 B |
43.06%
|
| Dec 31, 1999 | $72.05 B |
-21.50%
|
| Dec 31, 1998 | $91.78 B |
68.92%
|
| Dec 31, 1997 | $54.34 B |
81.92%
|
| Dec 31, 1996 | $29.87 B |
33.99%
|
| Dec 29, 1995 | $22.29 B |
66.70%
|
| Dec 30, 1994 | $13.37 B |
15.31%
|
| Dec 31, 1993 | $11.60 B |
-2.28%
|
| Dec 31, 1992 | $11.87 B |
-11.96%
|
| Dec 31, 1991 | $13.48 B |
112.77%
|
| Dec 31, 1990 | $6.34 B |
20.32%
|
| Dec 29, 1989 | $5.27 B |
24.17%
|
| Dec 30, 1988 | $4.24 B |
29.29%
|
| Dec 31, 1987 | $3.28 B |
-21.37%
|
| Dec 31, 1986 | $4.17 B |
23.99%
|
| Dec 31, 1985 | $3.36 B |
23.71%
|
| Dec 31, 1984 | $2.72 B |
22.78%
|
| Dec 30, 1983 | $2.22 B |
6.91%
|
| Dec 31, 1982 | $2.07 B |
33.45%
|
| Dec 31, 1981 | $1.55 B |
3.28%
|
| Dec 31, 1980 | $1.50 B |
39.97%
|
| Dec 31, 1979 | $1.07 B |
23.62%
|
| Dec 29, 1978 | $0.87 B |
25.58%
|
| Dec 30, 1977 | $0.69 B |
-2.87%
|
| Dec 31, 1976 | $0.71 B |
8.28%
|
| Dec 31, 1975 | $0.66 B |
-12.27%
|
| Dec 31, 1974 | $0.75 B |
-22.66%
|
| Dec 31, 1973 | $0.97 B |
2.50%
|
| Dec 29, 1972 | $0.95 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
 Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
 Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
 Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
 GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
 AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
 Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
 Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
 Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
 Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
 Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
 Biogen
BIIB
|
$20.75 B |
0.203 B
|
USA
|
| Market Cap | = | PFE Stock Price | * | PFE Shares Outstanding |
| = | $26.18 | * | 5.67 B | |
| = | $148.34 B |